ByteDance Seed AI4S Team Considers Spinoff as Key Members Xiao Wenzhi and Gu Quanquan Launch AI Drug Discovery Startup

According to Beating, ByteDance's Seed AI for Science (AI4S) team is discussing a potential spinoff, with core members including UCLA Associate Professor Gu Quanquan and computational biologist Xiao Wenzhi having recently departed to found an AI-focused drug discovery and protein design company. The startup has secured multiple funding rounds from leading U.S. venture capital firms. The team's key achievements include Protenix, an open-source reproduction of AlphaFold 3, and PXDesign, which outperforms AlphaProteo in protein binder design. Within ByteDance, the AI4S team has undergone multiple organizational restructuring cycles, with its reporting line shifting between different department heads.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments